HUMAN TRYPANOSOMIASIS CAUSED BY TRYPANOSOMA EVANSI IN INDIA: THE FIRST CASE REPORT
Prashant Joshi, VIJAY R. SHEGOKAR, R M Powar, Stéphane Herder, RAHUL KATTI, Harsha R. Salkar, Vibhawari Dani, Aradhana Bhargava, J Jannin, Philippe Truc
Abstract
Prashant Joshi, VIJAY R. SHEGOKAR, R M Powar, Stéphane Herder, RAHUL KATTI, Harsha R. Salkar, Vibhawari Dani, Aradhana Bhargava, J Jannin, Philippe Truc
Abstract
We report an Indian farmer who had fluctuating trypanosome parasitemia associated with febrile episodes for five months. Morphologic examination of the parasites indicated the presence of large numbers of trypanosomes belonging to the species Trypanosoma evansi, which is normally a causative agent of animal trypanosomiasis known as surra. Basic clinical and biologic examinations are described, using several assays, including parasitologic, serologic, and molecular biologic tests, all of which confirmed the infecting species as T. evansi. Analysis of cerebrospinal fluid indicated no invasion of the central nervous system (CNS) by trypanosomes. Suramin, a drug used exclusively for treatment of early-stage human African trypanosomiasis with no CNS involvement, effected apparent cure in the patient. This is the first case reported of human infection due to Trypanosoma evansi, which was probably caused by transmission of blood from an infected animal.
OpenAlex reports 308 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
We report an Indian farmer who had fluctuating trypanosome parasitemia associated with febrile episodes for five months. Morphologic examination of the parasites indicated the presence of large numbers of trypanosomes belonging to the species Trypanosoma evansi, which is normally a causative agent of animal trypanosomiasis known as surra. Basic clinical and biologic examinations are described, using several assays, including parasitologic, serologic, and molecular biologic tests, all of which confirmed the infecting species as T. evansi. Analysis of cerebrospinal fluid indicated no invasion of the central nervous system (CNS) by trypanosomes. Suramin, a drug used exclusively for treatment of early-stage human African trypanosomiasis with no CNS involvement, effected apparent cure in the patient. This is the first case reported of human infection due to Trypanosoma evansi, which was probably caused by transmission of blood from an infected animal.
Key concepts: Trypanosoma evansi, Trypanosomiasis, Parasitemia, Biology, Trypanosoma, African trypanosomiasis, Suramin, Virology